HIF2A mediates lineage transition to aggressive phenotype of cancer-associated fibroblasts in lung cancer brain metastasis
Brain metastasis is the most devasting form of lung cancer. Recent studies highlight significant differences in the tumor microenvironment (TME) between lung cancer brain metastasis (LCBM) and primary lung cancer, which contribute significantly to tumor progression and drug resistance. Cancer-associ...
Saved in:
| Published in | Oncoimmunology Vol. 13; no. 1; p. 2356942 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Taylor & Francis
2024
Taylor & Francis Group |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Brain metastasis is the most devasting form of lung cancer. Recent studies highlight significant differences in the tumor microenvironment (TME) between lung cancer brain metastasis (LCBM) and primary lung cancer, which contribute significantly to tumor progression and drug resistance. Cancer-associated fibroblasts (CAFs) are the major component of pro-tumor TME with high plasticity. However, the lineage composition and function of CAFs in LCBM remain elusive. By reanalyzing single-cell RNA sequencing (scRNA-seq) data (GSE131907) from lung cancer patients with different stages of metastasis comprising primary lesions and brain metastasis, we found that CAFs undergo distinctive lineage transition during LCBM under a hypoxic situation, which is directly driven by hypoxia-induced HIF-2α activation. Transited CAFs enhance angiogenesis through VEGF pathways, trigger metabolic reprogramming, and promote the growth of tumor cells. Bulk RNA sequencing data was utilized as validation cohorts. Multiplex immunohistochemistry (mIHC) assay was performed on four paired samples of brain metastasis and their primary lung cancer counterparts to validate the findings. Our study revealed a novel mechanism of lung cancer brain metastasis featuring HIF-2α-induced lineage transition and functional alteration of CAFs, which offers potential therapeutic targets. |
|---|---|
| AbstractList | Brain metastasis is the most devasting form of lung cancer. Recent studies highlight significant differences in the tumor microenvironment (TME) between lung cancer brain metastasis (LCBM) and primary lung cancer, which contribute significantly to tumor progression and drug resistance. Cancer-associated fibroblasts (CAFs) are the major component of pro-tumor TME with high plasticity. However, the lineage composition and function of CAFs in LCBM remain elusive. By reanalyzing single-cell RNA sequencing (scRNA-seq) data (GSE131907) from lung cancer patients with different stages of metastasis comprising primary lesions and brain metastasis, we found that CAFs undergo distinctive lineage transition during LCBM under a hypoxic situation, which is directly driven by hypoxia-induced HIF-2α activation. Transited CAFs enhance angiogenesis through VEGF pathways, trigger metabolic reprogramming, and promote the growth of tumor cells. Bulk RNA sequencing data was utilized as validation cohorts. Multiplex immunohistochemistry (mIHC) assay was performed on four paired samples of brain metastasis and their primary lung cancer counterparts to validate the findings. Our study revealed a novel mechanism of lung cancer brain metastasis featuring HIF-2α-induced lineage transition and functional alteration of CAFs, which offers potential therapeutic targets. ABSTRACTBrain metastasis is the most devasting form of lung cancer. Recent studies highlight significant differences in the tumor microenvironment (TME) between lung cancer brain metastasis (LCBM) and primary lung cancer, which contribute significantly to tumor progression and drug resistance. Cancer-associated fibroblasts (CAFs) are the major component of pro-tumor TME with high plasticity. However, the lineage composition and function of CAFs in LCBM remain elusive. By reanalyzing single-cell RNA sequencing (scRNA-seq) data (GSE131907) from lung cancer patients with different stages of metastasis comprising primary lesions and brain metastasis, we found that CAFs undergo distinctive lineage transition during LCBM under a hypoxic situation, which is directly driven by hypoxia-induced HIF-2α activation. Transited CAFs enhance angiogenesis through VEGF pathways, trigger metabolic reprogramming, and promote the growth of tumor cells. Bulk RNA sequencing data was utilized as validation cohorts. Multiplex immunohistochemistry (mIHC) assay was performed on four paired samples of brain metastasis and their primary lung cancer counterparts to validate the findings. Our study revealed a novel mechanism of lung cancer brain metastasis featuring HIF-2α-induced lineage transition and functional alteration of CAFs, which offers potential therapeutic targets. Brain metastasis is the most devasting form of lung cancer. Recent studies highlight significant differences in the tumor microenvironment (TME) between lung cancer brain metastasis (LCBM) and primary lung cancer, which contribute significantly to tumor progression and drug resistance. Cancer-associated fibroblasts (CAFs) are the major component of pro-tumor TME with high plasticity. However, the lineage composition and function of CAFs in LCBM remain elusive. By reanalyzing single-cell RNA sequencing (scRNA-seq) data (GSE131907) from lung cancer patients with different stages of metastasis comprising primary lesions and brain metastasis, we found that CAFs undergo distinctive lineage transition during LCBM under a hypoxic situation, which is directly driven by hypoxia-induced HIF-2α activation. Transited CAFs enhance angiogenesis through VEGF pathways, trigger metabolic reprogramming, and promote the growth of tumor cells. Bulk RNA sequencing data was utilized as validation cohorts. Multiplex immunohistochemistry (mIHC) assay was performed on four paired samples of brain metastasis and their primary lung cancer counterparts to validate the findings. Our study revealed a novel mechanism of lung cancer brain metastasis featuring HIF-2α-induced lineage transition and functional alteration of CAFs, which offers potential therapeutic targets.Brain metastasis is the most devasting form of lung cancer. Recent studies highlight significant differences in the tumor microenvironment (TME) between lung cancer brain metastasis (LCBM) and primary lung cancer, which contribute significantly to tumor progression and drug resistance. Cancer-associated fibroblasts (CAFs) are the major component of pro-tumor TME with high plasticity. However, the lineage composition and function of CAFs in LCBM remain elusive. By reanalyzing single-cell RNA sequencing (scRNA-seq) data (GSE131907) from lung cancer patients with different stages of metastasis comprising primary lesions and brain metastasis, we found that CAFs undergo distinctive lineage transition during LCBM under a hypoxic situation, which is directly driven by hypoxia-induced HIF-2α activation. Transited CAFs enhance angiogenesis through VEGF pathways, trigger metabolic reprogramming, and promote the growth of tumor cells. Bulk RNA sequencing data was utilized as validation cohorts. Multiplex immunohistochemistry (mIHC) assay was performed on four paired samples of brain metastasis and their primary lung cancer counterparts to validate the findings. Our study revealed a novel mechanism of lung cancer brain metastasis featuring HIF-2α-induced lineage transition and functional alteration of CAFs, which offers potential therapeutic targets. |
| Author | Fu, Minjie Mao, Ying Zhu, Xianmin Zhuang, Zhengping Zhang, Licheng Hua, Wei Shen, Zhewei You, Muyuan Feng, Yuan |
| Author_xml | – sequence: 1 givenname: Muyuan surname: You fullname: You, Muyuan organization: Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China – sequence: 2 givenname: Minjie surname: Fu fullname: Fu, Minjie organization: Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China – sequence: 3 givenname: Zhewei surname: Shen fullname: Shen, Zhewei organization: Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China – sequence: 4 givenname: Yuan surname: Feng fullname: Feng, Yuan organization: Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China – sequence: 5 givenname: Licheng surname: Zhang fullname: Zhang, Licheng organization: Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China – sequence: 6 givenname: Xianmin surname: Zhu fullname: Zhu, Xianmin organization: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, China – sequence: 7 givenname: Zhengping surname: Zhuang fullname: Zhuang, Zhengping organization: Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA – sequence: 8 givenname: Ying surname: Mao fullname: Mao, Ying organization: Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China – sequence: 9 givenname: Wei surname: Hua fullname: Hua, Wei organization: Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38778816$$D View this record in MEDLINE/PubMed |
| BookMark | eNpVUk1r3DAQFSWlSdP8hBYde_FWH5bsPZUQmmYh0EsLvYmRPHIUvNJW8gbSX1-5uwnJXCTee_M0jN57chJTREI-crbirGdfBNeiZeL3SjDRroRUet2KN-RswZuFOHlxPyUXpdyzWpopLdfvyKnsu67vuT4jf2821-KSbnEIMGOhU4gII9I5QyxhDinSOVEYx4ylhAekuzuMaX7cIU2eOogOcwOlJLf0D9QHm5OdoMyFhkinfRyPKmozVGSLcyWhhPKBvPUwFbw4nufk1_W3n1c3ze2P75ury9vGtULPjeCtcLaX0PfOgXBSWicdayXrmNeDt5ozzjo1gGfCKa5d5z1Ura0Aci3PyebgOyS4N7sctpAfTYJg_gMpjwbyHNyEhgPYAZF7b2WruADkljMBlismAbF6fT147fa27sxhrIuaXpm-ZmK4M2N6MLxWHXhdHT4fHXL6s8cym20oDqcJIqZ9MZKptVBatYtUHaQup1Iy-ud3ODNLDsxTDsySA3PMQe379HLI566nX5f_AInFs64 |
| Cites_doi | 10.1038/nm.3394 10.1158/2159-8290.Cd-21-1714 10.1097/cej.0000000000000790 10.1016/j.ccell.2018.01.010 10.1038/s12276-019-0299-y 10.1073/pnas.2020490118 10.1038/s41421-021-00271-4 10.1016/j.cmet.2018.09.012 10.1056/NEJMoa1205119 10.1038/s41392-022-01080-1 10.1158/1078-0432.Ccr-20-0798 10.1016/j.jhep.2023.01.011 10.1093/neuonc/noaa028 10.1186/s13046-018-0996-8 10.1097/PPO.0b013e318172d6e1 10.1016/j.xinn.2021.100141 10.1186/s40425-018-0349-3 10.1038/s41467-022-30633-9 10.1038/kisup.2014.20 10.1038/s41591-019-0654-5 10.1038/s42003-024-06087-8 10.1038/s41467-022-29366-6 10.1126/science.ade2292 10.1186/s11658-022-00408-7 10.1056/NEJMoa2103425 10.1038/s41467-022-33365-y 10.1093/biostatistics/kxj037 10.1002/ijc.28848 10.1016/j.jcmgh.2020.09.003 10.1016/j.cell.2021.04.048 10.1038/s41596-020-0336-2 10.1073/pnas.0506580102 10.1038/s41467-022-34395-2 10.1016/j.lungcan.2014.07.020 10.1186/s12943-023-01876-x 10.1016/j.annonc.2023.10.090 10.1038/s41523-017-0008-8 10.1038/s41467-021-21246-9 10.1038/s41467-020-16164-1 10.1002/ctm2.1101 10.1186/s13059-014-0550-8 10.1016/j.phrs.2023.106851 10.1038/nmeth.4402 10.1038/s41592-019-0619-0 10.1016/j.celrep.2018.10.045 10.1007/978-1-0716-0301-7_7 10.1172/jci.insight.144368 10.1093/neuonc/noad017 10.6004/jnccn.2017.0050 10.18632/aging.102967 10.1001/jamaoncol.2021.4932 10.1038/s43018-021-00195-8 10.1016/j.immuni.2019.03.024 10.1038/nrc.2016.73 |
| ContentType | Journal Article |
| Copyright | 2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) |
| Copyright_xml | – notice: 2024 The Author(s). Published with license by Taylor & Francis Group, LLC. – notice: 2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM DOA |
| DOI | 10.1080/2162402X.2024.2356942 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Open Access: DOAJ - Directory of Open Access Journals |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| DocumentTitleAlternate | M. YOU ET AL |
| EISSN | 2162-402X |
| ExternalDocumentID | oai_doaj_org_article_1aabdee1ffb34512ae1b102ab1503aee 10_1080_2162402X_2024_2356942 38778816 |
| Genre | Journal Article |
| GroupedDBID | 00X 0YH 4.4 53G AAKDD ABDBF ABUPF ACENM ACGFS ADBBV ADCVX AENEX AIJEM ALMA_UNASSIGNED_HOLDINGS AOIJS BABNJ BLEHA CCCUG CGR CUY CVF DEAQA DGEBU DGFLZ EBD EBS ECM EIF EJD EUPTU GROUPED_DOAJ H13 HYE KRBQP KSSTO KTTOD KWAYT KYCEM LJTGL M4Z NPM O9- OK1 OVD RPM TDBHL TEORI TFL TFW TNTFI TTHFI AAYXX CITATION 7X8 5PM |
| ID | FETCH-LOGICAL-c426t-2142cb83a88cca2c33bc3c043070f6dfb6101075daf02c516c7ffa8ccbaf0e163 |
| IEDL.DBID | RPM |
| ISSN | 2162-402X 2162-4011 |
| IngestDate | Tue Oct 22 15:12:52 EDT 2024 Tue Sep 17 21:28:36 EDT 2024 Sat Oct 26 04:30:55 EDT 2024 Fri Aug 23 03:06:03 EDT 2024 Tue Oct 29 09:21:20 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | lung cancer tumor microenvironment HIF Brain metastasis Cancer-Associated Fibroblasts |
| Language | English |
| License | 2024 The Author(s). Published with license by Taylor & Francis Group, LLC. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c426t-2142cb83a88cca2c33bc3c043070f6dfb6101075daf02c516c7ffa8ccbaf0e163 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contribute equally to this study. |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110709/ |
| PMID | 38778816 |
| PQID | 3059256549 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_1aabdee1ffb34512ae1b102ab1503aee pubmedcentral_primary_oai_pubmedcentral_nih_gov_11110709 proquest_miscellaneous_3059256549 crossref_primary_10_1080_2162402X_2024_2356942 pubmed_primary_38778816 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-00-00 |
| PublicationDateYYYYMMDD | 2024-01-01 |
| PublicationDate_xml | – year: 2024 text: 2024-00-00 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Oncoimmunology |
| PublicationTitleAlternate | Oncoimmunology |
| PublicationYear | 2024 |
| Publisher | Taylor & Francis Taylor & Francis Group |
| Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Group |
| References | e_1_3_10_26_1 e_1_3_10_24_1 e_1_3_10_47_1 e_1_3_10_28_1 e_1_3_10_49_1 e_1_3_10_4_1 e_1_3_10_54_1 e_1_3_10_2_1 e_1_3_10_8_1 e_1_3_10_12_1 e_1_3_10_33_1 e_1_3_10_50_1 e_1_3_10_6_1 e_1_3_10_10_1 e_1_3_10_31_1 e_1_3_10_52_1 e_1_3_10_15_1 e_1_3_10_38_1 e_1_3_10_13_1 e_1_3_10_36_1 e_1_3_10_19_1 e_1_3_10_17_1 e_1_3_10_41_1 e_1_3_10_43_1 e_1_3_10_45_1 e_1_3_10_22_1 e_1_3_10_20_1 e_1_3_10_27_1 e_1_3_10_25_1 e_1_3_10_46_1 e_1_3_10_29_1 e_1_3_10_48_1 e_1_3_10_30_1 e_1_3_10_53_1 e_1_3_10_5_1 e_1_3_10_55_1 e_1_3_10_3_1 e_1_3_10_11_1 e_1_3_10_34_1 e_1_3_10_9_1 e_1_3_10_32_1 e_1_3_10_51_1 e_1_3_10_7_1 e_1_3_10_16_1 e_1_3_10_37_1 e_1_3_10_14_1 e_1_3_10_35_1 e_1_3_10_18_1 e_1_3_10_39_1 e_1_3_10_40_1 e_1_3_10_44_1 e_1_3_10_23_1 e_1_3_10_21_1 e_1_3_10_42_1 |
| References_xml | – ident: e_1_3_10_16_1 doi: 10.1038/nm.3394 – ident: e_1_3_10_45_1 doi: 10.1158/2159-8290.Cd-21-1714 – ident: e_1_3_10_5_1 doi: 10.1097/cej.0000000000000790 – ident: e_1_3_10_38_1 doi: 10.1016/j.ccell.2018.01.010 – ident: e_1_3_10_49_1 doi: 10.1038/s12276-019-0299-y – ident: e_1_3_10_36_1 doi: 10.1073/pnas.2020490118 – ident: e_1_3_10_44_1 doi: 10.1038/s41421-021-00271-4 – ident: e_1_3_10_43_1 doi: 10.1016/j.cmet.2018.09.012 – ident: e_1_3_10_51_1 doi: 10.1056/NEJMoa1205119 – ident: e_1_3_10_35_1 doi: 10.1038/s41392-022-01080-1 – ident: e_1_3_10_8_1 doi: 10.1158/1078-0432.Ccr-20-0798 – ident: e_1_3_10_39_1 doi: 10.1016/j.jhep.2023.01.011 – ident: e_1_3_10_13_1 doi: 10.1093/neuonc/noaa028 – ident: e_1_3_10_37_1 doi: 10.1186/s13046-018-0996-8 – ident: e_1_3_10_4_1 doi: 10.1097/PPO.0b013e318172d6e1 – ident: e_1_3_10_26_1 doi: 10.1016/j.xinn.2021.100141 – ident: e_1_3_10_7_1 doi: 10.1186/s40425-018-0349-3 – ident: e_1_3_10_34_1 doi: 10.1038/s41467-022-30633-9 – ident: e_1_3_10_47_1 doi: 10.1038/kisup.2014.20 – ident: e_1_3_10_22_1 doi: 10.1038/s41591-019-0654-5 – ident: e_1_3_10_40_1 doi: 10.1038/s42003-024-06087-8 – ident: e_1_3_10_42_1 doi: 10.1038/s41467-022-29366-6 – ident: e_1_3_10_41_1 doi: 10.1126/science.ade2292 – ident: e_1_3_10_48_1 doi: 10.1186/s11658-022-00408-7 – ident: e_1_3_10_54_1 doi: 10.1056/NEJMoa2103425 – ident: e_1_3_10_12_1 doi: 10.1038/s41467-022-33365-y – ident: e_1_3_10_23_1 doi: 10.1093/biostatistics/kxj037 – ident: e_1_3_10_20_1 doi: 10.1002/ijc.28848 – ident: e_1_3_10_46_1 doi: 10.1016/j.jcmgh.2020.09.003 – ident: e_1_3_10_24_1 doi: 10.1016/j.cell.2021.04.048 – ident: e_1_3_10_32_1 doi: 10.1038/s41596-020-0336-2 – ident: e_1_3_10_27_1 doi: 10.1073/pnas.0506580102 – ident: e_1_3_10_18_1 doi: 10.1038/s41467-022-34395-2 – ident: e_1_3_10_3_1 doi: 10.1016/j.lungcan.2014.07.020 – ident: e_1_3_10_19_1 doi: 10.1186/s12943-023-01876-x – ident: e_1_3_10_55_1 doi: 10.1016/j.annonc.2023.10.090 – ident: e_1_3_10_21_1 doi: 10.1038/s41523-017-0008-8 – ident: e_1_3_10_30_1 doi: 10.1038/s41467-021-21246-9 – ident: e_1_3_10_9_1 doi: 10.1038/s41467-020-16164-1 – ident: e_1_3_10_17_1 doi: 10.1002/ctm2.1101 – ident: e_1_3_10_25_1 doi: 10.1186/s13059-014-0550-8 – ident: e_1_3_10_50_1 doi: 10.1016/j.phrs.2023.106851 – ident: e_1_3_10_31_1 doi: 10.1038/nmeth.4402 – ident: e_1_3_10_29_1 doi: 10.1038/s41592-019-0619-0 – ident: e_1_3_10_33_1 doi: 10.1016/j.celrep.2018.10.045 – ident: e_1_3_10_28_1 doi: 10.1007/978-1-0716-0301-7_7 – ident: e_1_3_10_52_1 doi: 10.1172/jci.insight.144368 – ident: e_1_3_10_10_1 doi: 10.1093/neuonc/noad017 – ident: e_1_3_10_6_1 doi: 10.6004/jnccn.2017.0050 – ident: e_1_3_10_53_1 doi: 10.18632/aging.102967 – ident: e_1_3_10_2_1 doi: 10.1001/jamaoncol.2021.4932 – ident: e_1_3_10_14_1 doi: 10.1038/s43018-021-00195-8 – ident: e_1_3_10_11_1 doi: 10.1016/j.immuni.2019.03.024 – ident: e_1_3_10_15_1 doi: 10.1038/nrc.2016.73 |
| SSID | ssj0000605639 |
| Score | 2.3849554 |
| Snippet | Brain metastasis is the most devasting form of lung cancer. Recent studies highlight significant differences in the tumor microenvironment (TME) between lung... ABSTRACTBrain metastasis is the most devasting form of lung cancer. Recent studies highlight significant differences in the tumor microenvironment (TME)... |
| SourceID | doaj pubmedcentral proquest crossref pubmed |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | 2356942 |
| SubjectTerms | Animals Basic Helix-Loop-Helix Transcription Factors - genetics Basic Helix-Loop-Helix Transcription Factors - metabolism Brain metastasis Brain Neoplasms - genetics Brain Neoplasms - metabolism Brain Neoplasms - pathology Brain Neoplasms - secondary Cancer-Associated Fibroblasts Cancer-Associated Fibroblasts - metabolism Cancer-Associated Fibroblasts - pathology Cell Line, Tumor Cell Lineage Gene Expression Regulation, Neoplastic HIF Humans lung cancer Lung Neoplasms - genetics Lung Neoplasms - metabolism Lung Neoplasms - pathology Lung Neoplasms - secondary Mice Neovascularization, Pathologic - genetics Neovascularization, Pathologic - metabolism Neovascularization, Pathologic - pathology Original Research Phenotype Single-Cell Analysis Tumor Microenvironment |
| SummonAdditionalLinks | – databaseName: Open Access: DOAJ - Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSyQxEA6LIOxlWd2Hra5E2GuP3Uk_kqO7OIwLenJgbk3ltQ5I9-K0h_XXW9XpkRkRvHhNAgn5kqqvksoXxn6CEi53dZWGkJm0CKXGLQV1iuTEIlvWIkpsXF1Xs3nxZ1EuNr76opywKA8cJ-4sBzDO-zwEIwv0TuBzg04RDDIZCd4P1jfTG8FUtMHo2KVeP9lR2ZnIK7pIWGBIKIqJkGWlC7HljAbN_teI5st8yQ0HNP3MPo3MkZ_HEe-xD77dZ7vxL8n_X9jj7HIqzvnwEgTpIyf6iLaC9-SMhrws3ncc_g7xNZo4TsldHZ3A8i5wS-DfpzCC5R0PGEd3Brl1v-LLlt-hURhbcUPfSmBPPVbCarn6yubTi5vfs3T8WCG16JD7lGTWrFESlEIAhZXSWGlJ_avOQuWCQU6FYWHpIGTClnll6xAA2xos8MjgvrGdtmv9AeNlKWsNma-U04XRDmpl6TY3867OSwMJm6xnuPkX9TOafJQlXUPSECTNCEnCfhEOz41J_noowEXRjIuieWtRJOx0jWKD24XuQKD13cOqQfOmkeVhVJyw7xHV566kqklcv0qY2sJ7ayzbNe3ydpDkJseDk6cP32P0R-wjzUg86DlmO_39g_-B1Kc3J8MqfwKAZQQR priority: 102 providerName: Directory of Open Access Journals |
| Title | HIF2A mediates lineage transition to aggressive phenotype of cancer-associated fibroblasts in lung cancer brain metastasis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38778816 https://www.proquest.com/docview/3059256549 https://pubmed.ncbi.nlm.nih.gov/PMC11110709 https://doaj.org/article/1aabdee1ffb34512ae1b102ab1503aee |
| Volume | 13 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB6ygUAupW36cNMuCvTqXVvyQz6mocu2kJBDAtuT0TNdSOyw6xzaX58Z2Q7Z0FOvsoyNvtHMN9LoE8BXJblNbVnE3ic6znxe4ZRSZYzkxCBbrngvsXF-USyvs5-rfLUHxXgWJhTtG72eNbd3s2b9O9RW3t-Z-VgnNr88P6NpjqZazScwQQt9lqP3_heDerhCjKd0JAgteDy6I5M5tWHOtMLUkGczLvKiyvhOUAra_f8inC_rJp8FosVreDUwSHba_-kb2HPNWzjo75T8cwR_lz8W_JSFEyFIIxnRSPQZrKOgFOqzWNcydRPybHR1jIq8WlqJZa1nhoxgE6sBNGeZx3y61cixuy1bN-wWncPQi2m6XgK_1OFDtV1v38H14vvV2TIeLliIDQbmLia5NaOlUFIikNwIoY0wpAJWJr6wXiO3woHOrfIJN3lamNJ7hX01Njhkcu9hv2kb9xFYnouyUokrpK0yXVlVSkO7uomzZZprFcFsHOH6vtfRqNNBnnSEpCZI6gGSCL4RDk-dSQY7NLSbm3owhjpVSlvnUu-1yJC6KJdqZExKI80VyrkITkYUa5w2tBeiGtc-bGt0cxWyPcyOI_jQo_r0KSFLEtkvIpA7eO_8y-4TtNQgzT1a5qf_f_UYDmkc-mWez7DfbR7cFyQ-nZ7CJPm1nIZlg2mw-UcgjQUy |
| link.rule.ids | 230,315,730,783,787,867,888,2109,4033,27937,27938,27939,53806,53808 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB2VIkQvfEPDp5G4JpvYieMcS8VqC92KQyv2ZtmOXVa0SbWbPdBfz9hJqm7FBa62o8SZN-M3yfgZ4JMStM7qksfOpTrOXVGhS6kyRnJikC1XtJfYmJ_w2Vn-dVEsdoCPe2FC0b7Ry6S5uEya5c9QW3l1aSZjndjk-_zQuzlCtZrcg_vosCm_laX3ERiX9XCIGM38piDE8Lh5R6QT34ZZ0wKTQ5onlBW8yunWshTU-_9GOe9WTt5aiqaP4cc4ib4C5Vey6XRiru_oO_77LJ_Ao4GdkoO-_yns2OYZPOjPq_z9HK5nR1N6QMJuE6SoxFNUjEek8wteqP0iXUvUecjhMYwSX0DW-q-8pHXEeICtYjUAwtbEYa7eauTv3ZosG3KBgWcYRbQ_ugLv1GGnWi_XL-Bs-uX0cBYPhzfEBhf9LvZSbkYLpoRAkFDDmDbMeIWxMnW8dhp5G06vqJVLqSkybkrnFI7V2GCRJb6E3aZt7D6QomBlpVLLRV3luqpVKYz_Y5zauswKrSJIRtvJq16jQ2aD9OlobOmNLQdjR_DZW_hmsJfYDg3t6lwOJpCZUrq2NnNOsxxpkbKZRjamNFJopqyN4OOID4ku6f-zqMa2m7XEEFohk8TMO4JXPV5ubsVE6QX8eQRiC0lbz7Ldg_gIst8jHl7__6Uf4OHsdH4sj49Ovr2BPf9O-s9Jb2G3W23sOyRYnX4fvOkPp2ElaA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BEYhLeZaGp5G45mXn4RxLYbUFWvVApZU4RH6WFW2y2mQP9NczdpKqW3Hq1fEq68w3M98k488AnwSnOtVlEVqbyDCzeYUuJcoQyYlCtlzRQWLj-KSYn2XfFvli7KrsxrbKRsll1FxcRs3yt--tXF2qeOoTi0-PD52bI1SreKVtfB8eoNMm_EalPkRhTO3-IDGauo1BiONpAw9PYjeGldMCC0SaRZTlRZXRrdTkFfz_Rztvd0_eSEezJ_BrWsjQhfIn2vQyUle3NB7vttKnsDuyVHIwzHkG90zzHB4O51b-fQFX86MZPSB-1wlSVeKoKsYl0rvE53vASN8Sce5reQynxDWSte5tL2ktUQ5o61CMwDCaWKzZW4k8vu_IsiEXGIDGWUS6IyzwTj1eFN2yewlns68_D-fheIhDqDD596GTdFOSM8E5goUqxqRiyimNlYkttJXI33CJuRY2oSpPC1VaK3CuxAGDbHEPdpq2MftA8pyVlUhMwXWVyUqLkiv35TgxukxzKQKIJvvVq0Gro05HCdTJ4LUzeD0aPIDPzsrXk53Uth9o1-f1aIY6FUJqY1JrJcuQHgmTSmRlQiKVZsKYAD5OGKnRNd33FtGYdtPVGEorZJRYgQfwasDM9a0YL52QfxEA30LT1n_ZvoIY8fLfEyZe3_2nH-DR6ZdZ_ePo5PsbeOweyfBW6S3s9OuNeYc8q5fvvUP9A8cjJ-g |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HIF2A+mediates+lineage+transition+to+aggressive+phenotype+of+cancer-associated+fibroblasts+in+lung+cancer+brain+metastasis&rft.jtitle=Oncoimmunology&rft.au=You%2C+Muyuan&rft.au=Fu%2C+Minjie&rft.au=Shen%2C+Zhewei&rft.au=Feng%2C+Yuan&rft.date=2024&rft.issn=2162-402X&rft.eissn=2162-402X&rft.volume=13&rft.issue=1&rft_id=info:doi/10.1080%2F2162402X.2024.2356942&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_2162402X_2024_2356942 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2162-402X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2162-402X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2162-402X&client=summon |